-
Aperture Bio
Realizing orders-of-magnitude improvements in speed and sensitivity, Aperture rapidly analyzes proteins in whole cells to map immune interactions.
![Aperture Bio team]()
-
Beacon Bio
Improving hearing and healing by restoring eardrums with regenerative grafts.
![Beacon team]()
-
Chaku Foods
Creating wealth for smallholder farmers in Africa while minimizing climate risk.
![Chaku Foods founder]()
-
Concerto Biosciences
Discovering microbial ensembles for health via a patented screening platform.
![Concerto Biosciences team]()
-
InGel Therapeutics
Regenerative cell-therapy biotech aiming to treat people affected by blindness.
![InGel team]()
-
Manifold Bio
Designing tissue-specific medicines in living systems from the start by combining high-throughput in-vivo studies with AI-guided protein design.
![Manifold team]()
-
My Dental Key
An online platform that helps students learn clinical and preclinical dentistry.
![My Dental Key team]()
-
Stochastic
An enterprise platform for businesses to build, customize, and control their own AI.
![Stochastic team]()
-
Stratagen Bio
Transforming MRI scans into a tool for objective clinical decision-making and quantitative biomarker assessment.
![]()
-
The Apprentice Project
Leveraging artificial intelligence (AI) and machine learning (ML) to provide personalized learning experiences and support to students across India.
![Apprentice Project team]()
-
THRIVE!
Building a software platform that helps state and local government agencies—including school systems—create budgets that mitigate disparities experienced by low-income residents and people of color.
![Thrive founder]()
-
Transcera
Transforming chronic disease treatment through improved biologic drug delivery.
-
Tuverl
An app that makes public transport cheaper and more accessible to millions of commuters across Africa.
![Tuverl team]()
-
Umbulizer
Developing a reliable, low-cost, and portable device that can provide continuous ventilation to patients.
![Umbulizer team]()
Take On the Challenge
Students: Apply for the PIC by Dec. 05.
